Retrospective Cohort Study on Asian Patients with Hidradenitis Suppurativa: Factors Associated with the Efficacy of Antibiotic Treatment
DOI:
https://doi.org/10.2340/actadv.v102.2282Keywords:
clindamycin, hidradenitis suppurativa, tetracycline, treatment responseAbstract
Abstract is missing (Short communication)
Downloads
References
Saunte DML, Jemec GBE. Hidradenitis suppurativa: advances in diagnosis and treatment. JAMA 2017; 318: 2019-2032.
https://doi.org/10.1001/jama.2017.16691 DOI: https://doi.org/10.1001/jama.2017.16691
Lee JH, Kwon HS, Jung HM, Kim GM, Bae JM. Prevalence and comorbidities associated with hidradenitis suppurativa in Korea: a nationwide population-based study. J Eur Acad Dermatol Venereol 2018; 32: 1784-1790.
https://doi.org/10.1111/jdv.15071 DOI: https://doi.org/10.1111/jdv.15071
Omine T, Miyagi T, Hayashi K, Yamaguchi S, Takahashi K. Clinical characteristics of hidradenitis suppurativa patients in Okinawa, Japan: differences between East Asia and Western countries. J Dermatol 2020; 47: 855-862.
https://doi.org/10.1111/1346-8138.15411 DOI: https://doi.org/10.1111/1346-8138.15411
Goldburg SR, Strober BE, Payette MJ. Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol 2020; 82: 1045-1058.
https://doi.org/10.1016/j.jaad.2019.08.090 DOI: https://doi.org/10.1016/j.jaad.2019.08.090
Zouboulis CC, Tzellos T, Kyrgidis A, Jemec GBE, Bechara FG, Giamarellos-Bourboulis EJ, et al; European Hidradenitis Suppurativa Foundation Investigator Group. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity. Br J Dermatol 2017; 177: 1401-1409.
https://doi.org/10.1111/bjd.15748 DOI: https://doi.org/10.1111/bjd.15748
Caposiena Caro RD, Cannizzaro MV, Botti E, Di Raimondo C, Di Matteo E, Gaziano R, et al. Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: clinical and ultrasound observations. J Am Acad Dermatol 2019; 80: 1314-1321.
https://doi.org/10.1016/j.jaad.2018.11.035 DOI: https://doi.org/10.1016/j.jaad.2018.11.035
Rosi E, Pescitelli L, Ricceri F, Di Cesare A, Novelli A, Pimpinelli N, et al. Clindamycin as unique antibiotic choice in hidradenitis suppurativa. Dermatol Ther 2019; 32: e12792.
https://doi.org/10.1111/dth.12792 DOI: https://doi.org/10.1111/dth.12792
Delaunay J, Villani AP, Guillem P, Tristan A, Boibieux A, Jullien D. Oral ofloxacin and clindamycin as an alternative to the classic rifampicin-clindamycin in hidradenitis suppurativa: retrospective analysis of 65 patients. Br J Dermatol 2018; 178: e15-e16.
https://doi.org/10.1111/bjd.15739 DOI: https://doi.org/10.1111/bjd.15739
Garg A, Malviya N, Strunk A, Wright S, Alavi A, Alhusayen R, et al. Comorbidity screening in hidradenitis suppurativa: evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations. J Am Acad Dermatol 2022; 86: 1092-1101.
https://doi.org/10.1016/j.jaad.2021.01.059 DOI: https://doi.org/10.1016/j.jaad.2021.01.059
Denny G, Anadkat MJ. The effect of smoking and age on the response to first-line therapy of hidradenitis suppurativa: an institutional retrospective cohort study. J Am Acad Dermatol 2017; 76: 54-59.
https://doi.org/10.1016/j.jaad.2016.07.041 DOI: https://doi.org/10.1016/j.jaad.2016.07.041
Iannone M, Janowska A, Bartolomei G, Puntoni M, Oranges T, Romanelli M, et al. Systemic antibiotics in hidradenitis suppurativa: efficacy and effects of body mass index and smoking pack-year on the response to therapy. Dermatol Ther 2021; 34: e14919.
https://doi.org/10.1111/dth.14919 DOI: https://doi.org/10.1111/dth.14919
Pan WH, Yeh WT. How to define obesity? Evidence-based multiple action points for public awareness, screening, and treatment: an extension of Asian-Pacific recommendations. Asia Pac J Clin Nutr 2008; 17: 370-374.
Martorell A, Jfri A, Koster SBL, Gomez-Palencia P, Solera M, Alfaro-Rubio A, et al. Defining hidradenitis suppurativa phenotypes based on the elementary lesion pattern: results of a prospective study. J Eur Acad Dermatol Venereol 2020; 34: 1309-1318.
https://doi.org/10.1111/jdv.16183 DOI: https://doi.org/10.1111/jdv.16183
van der Zee HH, Jemec GB. New insights into the diagnosis of hidradenitis suppurativa: Clinical presentations and phenotypes. J Am Acad Dermatol 2015; 73: S23-S26.
https://doi.org/10.1016/j.jaad.2015.07.047 DOI: https://doi.org/10.1016/j.jaad.2015.07.047
Additional Files
Published
How to Cite
License
Copyright (c) 2022 Yun Kyung Jang, Sujin Moon, Jung U. Shin, Dong Hyun Kim, Hee Jung Lee
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
